# Sergey Jakimov

> Sergey Jakimov is a seed investor at Longevity Science Foundation backing Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Longevity Science Foundation](https://shizune.co/investors/profile/longevity-science-foundation)
- Total investments: 3
- Last investment: Oct 2025
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jakimov
- Facebook: https://www.facebook.com/sergey.jakimov

Sergey Jakimov is a seed investor at Longevity Science Foundation focused on Health Care and Life Science. Serial entrepreneur, having co-founded 3 deep-tech ventures and raised more than $50 million in venture funding for his own ventures and as an entrepreneur in residence. He has worked with several other early-stage companies in the therapeutics space on fundraising, IP protection, and clinical trial strategies, focusing on early treatments incardiovascular, oncology, and neurodegenerative spaces. Visiting Lecturer to several universities on VC and intellectual property rights, co-authored a master's program in Technology Law for the Riga Graduate School of Law.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Life Science | 2 | 67% |
| Therapeutics | 2 | 67% |
| Biotechnology | 2 | 67% |
| Wellness | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 1 | 33% |
| United States | 1 | 33% |
| United Kingdom | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Valink Therapeutics | Valink Therapeutics is a health care drug discovery for next-generation cancer treatments. | $11.8M | Seed | Oct 20, 2025 |  |
| Catena Biosciences | Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research. | $2.4M | Seed | May 10, 2024 |  |
| PreComb | PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients. | $1.3M | Seed | Oct 04, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Kinled Holding](https://shizune.co/investors/profile/kinled) — VC Fund, 2 deals together
- [BrightEdge - American Cancer Society](https://shizune.co/investors/profile/brightedge-american-cancer-society) — VC Fund, 1 deal together
- [Caffeinated Capital](https://shizune.co/investors/profile/caffeinated-capital) — VC Fund, 1 deal together
- [California Innovation Fund](https://shizune.co/investors/profile/california-innovation-fund) — VC Fund, 1 deal together
- [Civilization Ventures](https://shizune.co/investors/profile/civilization-ventures) — VC Fund, 1 deal together
- [Freeflow Ventures](https://shizune.co/investors/profile/freeflow-ventures) — VC Fund, 1 deal together

## About Longevity Science Foundation

VC Fund



2 contacts available at Longevity Science Foundation.

| Name | Title | Profile |
| --- | --- | --- |
| Sergey Jakimov | Co-Founder | https://shizune.co/investors/profile/sergey-jakimov |
| Garri Zmudze | Executive Coordinator | https://shizune.co/investors/profile/garri-zmudze |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Sergey Jakimov invest in?

Sergey Jakimov invests primarily in Health Care, Life Science and Therapeutics startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sergey Jakimov last invest?

The most recent investment recorded for Sergey Jakimov closed in Oct 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co